Abstract
Crohn’s disease most frequently presents in late adolescence or early adulthood and is equally distributed between the genders [1]. Symptoms at presentation vary depending on the location, behaviour and severity of disease, as well as extraintestinal manifestations and medication. The aim is to establish the diagnosis and distribution of disease using appropriate techniques, since this influences the choice of therapy. Originally, Dr. Burrill Crohn and colleagues described regional ileitis as a chronic inflammatory disease restricted to the terminal ileum in association with intestinal stenoses or fistulae, but not crossing the ileocaecal valve [2]. Although Crohn subsequently recognised colonic disease in conjunction with ileitis [3], it was Basil Morson and Lyn Lockhart-Mummery who put colonic Crohn’s disease on the diagnostic map [4, 5].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Stange EF, Travis SP, Vermeire S, et al. European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis. Gut 2006;55:i1–i15
Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis. J Am Med Assoc 1932;99:1323–1329
Crohn BB, Rosenak BD. A combined form of ileitis and colitis. J Am Med Assoc 1936;106:1–7
Morson BC, Lockhart-Mummery HE. Crohn’s disease of the colon. Gastroenterologia 1959;92:168–173
Lockhart-Mummery HE, Morson BC. Crohn’s disease (regional enteritis) of the large intestine and its distinction from ulcerative colitis. Gut 1960;1:87–105
Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005;19:5A–36A
Sands BE. From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation. Gastroenterology 2004;126:1518–1532
Lennard-Jones JE, Shivananda S, the EC-IBD Study Group. Clinical uniformity of inflammatory bowel disease at presentation and during the first year of disease in the north and south of Europe. Eur J Gastroenterol Hepatol 1997;9:353–359
Caprilli R, Gassull MA, Escher JC, et al. European evidence based consensus on the diagnosis and management of Crohn’s disease: special situations. Gut 2006;55:i36–i58
Hellers G, Bergstrand O, Ewerth S, et al. Occurrence and outcome after primary treatment of anal fistulae in Crohn’s disease. Gut 1980;21:525–527
Schwartz DA, Loftus EV Jr, Tremaine WJ, et al. The natural history of fistulizing Crohn’s disease in Olmsted County, Minnesota. Gastroenterology 2002;122:875–880
Pera A, Bellando P, Caldera D, et al. Colonoscopy in inflammatory bowel disease. Diagnostic accuracy and proposal of an endoscopic score. Gastroenterology 1987;92:181–185
Nahon S, Bouhnik Y, Lavergne-Slove A, et al. Colonoscopy accurately predicts the anatomical severity of colonic Crohn’s disease attacks: correlation with findings from colectomy specimens. Am J Gastroenterol 2002;97:3102–3107
Ota Y, Matsui T, Ono H, et al. Value of virtual computed tomographic colonography for Crohn’s colitis: comparison with endoscopy and barium enema. Abdom Imaging 2003;28:778–783
Geboes K. Pathology of inflammatory bowel diseases (IBD): variability with time and treatment. Colorectal disease 2001;3:2–12
Low RN, Francis IR, Politoske D, et al. Crohn’s disease evaluation: comparison of contrast-enhanced MR imaging and single-phase helical CT scanning. J Magn Reson Imaging 2000;11:127–135
Haggett PJ, Moore NR, Shearman JD, et al. Pelvic and perineal complications of Crohn’s disease: assessment using magnetic resonance imaging. Gut 1995;36:407–410
Price AB. Overlap in the spectrum of non-specific inflammatory bowel disease – ‘colitis indeterminate’. J Clin Pathol 1978;31:567–577
Bell SJ, Williams AB, Wiesel P, et al. The clinical course of fistulating Crohn’s disease. Aliment Pharmacol Ther 2003;17:1145–1151
Parks AG, Gordon PH, Hardcastle J. A classification of fistula-in-ano. Br J Surg 1976;63:1–12
Sandborn WJ, Fazio VW, Feagan BG, et al. AGA technical review on perianal Crohn’s disease. Gastroenterology 2003;125:1508–1530
Travis SPL, Stange EF, Lémann M, et al. European evidence based consensus on the diagnosis and management of Crohn’s disease: current management. Gut 2006;55:i16–i35
Farmer RG, Whelan G, Fazio VW. Long-term follow-up of patients with Crohn’s disease. Relationship between the clinical pattern and prognosis. Gastroenterology 1985;88:1818–1825
Vermeire S, Louis E, Carbonez A, et al. Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn’s disease. Am J Gastro 2002;97:2357–2363
Sands BE, Anderson FH, Bernstein CN, et al. Infliximab maintenance therapy for fistulizing Crohn’s disease. N Engl J Med 2004;350:876–885
Lindsey I, Humphreys CM, George BD, et al. The role of anal ultrasound in the management of anal fistulas. Colorectal Dis 2002;4:118–122
Travis SPL. Advances in therapeutic approaches to ulcerative colitis and Crohn’s disease. Curr Gastroenterol Rep 2005;7:475–484
Sands BE, Blank MA, Patel K, et al. Long-term treatment of rectovaginal fistulas in Crohn’s disease: response to infliximab in the ACCENT II Study. Clin Gastroenterol Hepatol 2004;2:912–920
Sahmoud T, Hoctin-Boes G, Modigliani R, et al. Identifying patients with a high risk of relapse in quiescent Crohn’s disease. The GETAID Group. Gut 1995;37:811–818
Cosnes J, Carbonnel F, Beaugerie L, et al. Effects of cigarette smoking on the long-term course of Crohn’s disease. Gastroenterology 1996;110:424–431
Akobeng AK, Gardener E. Oral 5-aminosalicylic acid for maintenance of medically induced remission in Crohn’s disease. Cochrane Database Syst Rev 2005;(1):CD003715
Lémann M, Mary JY, Duclos B, et al. Infliximab plus azathioprine for steroid-dependent Crohn’s disease patients: a randomized placebo-controlled trial. Gastroenterology 2006;130:1054–1061
Travis SPL. Infliximab and azathioprine: bridge or parachute? Gastroenterology 2006;130:1354–1357
Siegel CA, Sands BE. Risk factors for colorectal cancer in Crohn’s colitis: a case-control study. Inflamm Bowel Dis 2006;12:491–496
Levine D, Reid B. Endoscopic biopsy technique for acquiring larger mucosal samples. Gastrointest Endosc 1991;37:332–337
Sjodahl RI, Myrelid P, Soderholm JD. Anal and rectal cancer in Crohn’s disease. Colorectal Dis 2003;5:490–495
Belaiche J, Louis E, D’Haens G, et al. Acute lower gastrointestinal bleeding in Crohn’s disease: characteristics of a unique series of 34 patients. Belgian IBD Research Group. Am J Gastroenterol 1999;94:2177–2181
Mortensen NJ, Ritchie JK, Hawley PR, et al. Surgery for acute Crohn’s colitis: results and long term follow up. Br J Surg 1984;71:783–784
Edwards CM, George BD, Jewell DP, et al. Role of a defunctioning stoma in the management of large bowel Crohn’s disease. Br J Surg 2000;87:1063–1066
Tekkis PP, Purkayastha S, Lanitis S, et al. A comparison of segmental vs subtotal/total colectomy for colonic Crohn’s disease: a meta analysis. Colorectal Dis 2006; 2:82–90
Roe AM, Mortensen NJ. Perineal reconstruction with rectus abdominus flap after resection of anal carcinoma in Crohn’s disease. J R Soc Med 1989;82:369–370
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Mortensen, N., Travis, S. (2010). Anorectal and Colonic Crohn’s Disease. In: Givel, JC., Mortensen, N., Roche, B. (eds) Anorectal and Colonic Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69419-9_30
Download citation
DOI: https://doi.org/10.1007/978-3-540-69419-9_30
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-69418-2
Online ISBN: 978-3-540-69419-9
eBook Packages: MedicineMedicine (R0)